This Week in Cardiology

This week's podcast covers topics such as the TACT2 trial of chelation therapy, inter-atrial shunts for heart failure, triglyceride lowering, diltiazem, and Factor Xa anticoagulants. It discusses the lack of benefit of chelation therapy post-MI, the mixed results of interatrial shunts for HF, and the potential of triglyceride reduction. Additionally, it explores the correlation between bleeding risk and the co-administration of diltiazem and Factor Xa inhibitors.

Cardiologist John Mandrola, MD, covers ACC Recap including Impella CP in STEMI, REDUCE-AMI challenging beta-blockers post-MI, Prevent trial showing reduced cardiac events with preventive PCI, and EMPACT-MI on SGT2 inhibitors in post-MI care. Topics include device enthusiasm caution, industry payments influencing LVAD utilization, challenging cardiology practices with beta blockers, and plaque vulnerability identification and treatment implications.

Cardiologist John Mandrola discusses statins and diabetes, AADs in heart disease patients, tricuspid valve interventions, and an ACC preview. Topics include statin therapy's link to new onset diabetes, efficacy of statin trials, FDA approval of TriClip for tricuspid regurgitation, and upcoming ACC trials like the danger shock trial comparing Impella vs. standard care in cardiogenic shock.

Cardiologist John Mandrola, MD, discusses topics like intermittent fasting, anticoagulation decisions, heterogenous treatment effects, frailty in HF, ECG importance, and industry conflicts. He covers studies on time-restricted eating, stroke prevention, and revised LBBB definition. The podcast is filled with insightful discussions for healthcare professionals.

Topics discussed include the use of obesity drugs as heart modifiers, the accuracy of wearable heart rate monitors, challenges in interpreting signals from trials, and the implications of study findings for individualized treatments in cardiology.

This podcast delves into the intriguing topics of plastics and heart disease, MINT trial LTE and Bayes theorem, and Brugada syndrome. The discussion explores the link between plastic particles in carotid plaques and CV events, the implications of test accuracy and prior probabilities in medical diagnostics, and the demographics and findings of Brugada Syndrome patients.

Topics discussed in the podcast include Western AF meeting, aspirin controversies, cannabis use's impact on cardiovascular risk, low EF in athletes, and shared decision making for ICD implantation. Insights into these healthcare topics provide valuable information for professionals.

This week, the podcast covers topics like reading incidental CAC on chest CT scans, exercise benefits in women vs men, PCI with or without imaging, and trial non-reporting. It discusses the implications of calcium scoring, sex differences in exercise benefits, the need for imaging guideline updates in PCI, and the challenges of trial non-reporting in medical research.

John Mandrola, MD discusses trial interpretation, CI, P-values, and percutaneous tricuspid interventions in the latest podcast. He also covers news on HDL cholesterol and the importance of humility in Medicine.

Topics discussed in the podcast include beta-blocker withdrawal in heart failure with preserved ejection fraction (HFpEF), negative trials of direct oral anticoagulants (DOAC) for stroke prevention, results of the Arcadia trial challenging perceptions of oral anticoagulation, using food as medicine in patients with diabetes, limitations of a cardiometabolic health program, and a study comparing bariatric surgery to medical therapy for hypertension in obese patients.